Progression of disease within 5 months of adult T-cell leukemia-lymphoma (ATL5) as a clinical endpoint for high-risk mortality outcomes

ANNALS OF ONCOLOGY(2023)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要